Inversion Frenzy Rocks Drug Sector

Drug maker Shire of Ireland rejected a $46 billion takeover bid from U.S. rival AbbVie, the latest attempt by an American company to buy a foreign address and the tax advantages that come with it.



from WSJ.com: US Business http://ift.tt/1nonF7c

via IFTTT